Journal: Frontiers in Immunology
Article Title: Inhibition of miRNA associated with a disease-specific signature and secreted via extracellular vesicles of systemic lupus erythematosus patients suppresses target organ inflammation in a humanized mouse model
doi: 10.3389/fimmu.2023.1090177
Figure Lengend Snippet: Schematic of the proposed mechanism of estrogen-mediated miR production and inflammation via extracellular vesicle signaling in SLE. Estrogen (E2) enters an immune cell, dimerizes with estrogen receptor (ER)α, translocates to the nucleus, and promotes the expression of miRNA (miR) processing machinery, including RNA polymerase III, Dicer1, AGO2, and Drosha. These miRs are packaged and secreted in EVs, which are taken up by recipient immune cells. When EV-derived miR cargo is taken up, it can function to regulate gene expression in the recipient cell via two pathways. The canonical pathway involves miRs binding to target mRNAs through the RNA-induced silencing complex (RISC). In the non-canonical pathway, EV-encapsulated miRs fuse with endosomes and bind to TRL7 or TLR8 to stimulate proinflammatory gene expression and additional EV secretion, which promotes SLE pathogenesis.
Article Snippet: Murine EVs isolated from plasma were submitted directly to System Biosciences (SBI) for RNA isolation and miRNA profiling according to the Exo-NGS service, exosomal RNA sequencing protocol.
Techniques: Expressing, Derivative Assay, Gene Expression, Binding Assay